RxDoctor Payments Data

Mark Gordin, MD

Psychiatry · Cranford, NJNPI 1588693642

Payments from drug & device makers

$2,090in general payments, 2019–2025

Across 147 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$556
  • AbbVie$394
  • Sunovion Pharmaceuticals Inc.$356
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$282
  • Johnson & Johnson$146
  • Teva Pharmaceuticals USA, Inc.$128
  • plus $228 from 6 others

What the payments were for

  • Food & beverage$2,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,090 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$80,429
Medicare patients
166
Services billed
1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$97,452
Abilify MaintenaAripiprazole34$94,218
Invega SustennaPaliperidone Palmitate23$70,541
AristadaAripiprazole Lauroxil14$45,732
Risperidone ErRisperidone Microspheres11$19,372
FetzimaLevomilnacipran Hcl23$11,398
Aripiprazole120$9,844
Clozapine110$9,225
TrintellixVortioxetine Hydrobromide11$6,110
Adderall XrDextroamphetamine/Amphetamine13$5,226
Lurasidone Hcl23$4,816
VyvanseLisdexamfetamine Dimesylate11$4,295
Fluphenazine Hcl36$4,059
Bupropion XlBupropion Hcl255$3,962
Clonazepam385$3,251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$14$97,45212 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$556$94,21834 claims
Johnson & JohnsonInvega Sustenna$146$70,54123 claims
Alkermes, Inc.Aristada$107$45,73214 claims
AbbVieFetzima$394$11,39823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Cranford

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →